◆英語タイトル：Global Blood Therapeutics Inc (GBT) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company’s lead drug candidate GBT440 is an oral, small molecule drug for the treatment of sickle cell disease. Its GBT440 is a hemoglobin modifier which targets the mechanism of red blood cell sickling for the treatment of SCD. GBT’s pipeline also includes an oral kallikrein inhibitor to prevent hereditary angioedema attacks. The company also develops therapies which are in preclinical and preliminary clinical stage for the treatment of for acute and chronic hypoxemic pulmonary disorders. It offers chemical and biological mechanisms of blood-based disorders. GBT is headquartered in South San Francisco, California, the US.
Global Blood Therapeutics Inc Key Recent Developments
Apr 08,2021: Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients
Mar 02,2021: GBT opens 2021 ACCEL grant program, providing up to $500,000 in support to the sickle cell disease community
This comprehensive SWOT profile of Global Blood Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Global Blood Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Global Blood Therapeutics Inc – Key Information
Global Blood Therapeutics Inc – Overview
Global Blood Therapeutics Inc – Key Employees
Global Blood Therapeutics Inc – Key Employee Biographies
Global Blood Therapeutics Inc – Key Operational Heads
Global Blood Therapeutics Inc – Major Products and Services
Global Blood Therapeutics Inc – History
Global Blood Therapeutics Inc – Company Statement
Global Blood Therapeutics Inc – Locations And Subsidiaries
Global Blood Therapeutics Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Global Blood Therapeutics Inc – Business Description
Global Blood Therapeutics Inc – Corporate Strategy
Global Blood Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Global Blood Therapeutics Inc – Strengths
Global Blood Therapeutics Inc – Weaknesses
Global Blood Therapeutics Inc – Opportunities
Global Blood Therapeutics Inc – Threats
Global Blood Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Global Blood Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Global Blood Therapeutics Inc, Key Information
Global Blood Therapeutics Inc, Key Ratios
Global Blood Therapeutics Inc, Share Data
Global Blood Therapeutics Inc, Major Products and Services
Global Blood Therapeutics Inc, History
Global Blood Therapeutics Inc, Key Employees
Global Blood Therapeutics Inc, Key Employee Biographies
Global Blood Therapeutics Inc, Key Operational Heads
Global Blood Therapeutics Inc, Other Locations
Global Blood Therapeutics Inc, Subsidiaries
Global Blood Therapeutics Inc, Key Competitors
Global Blood Therapeutics Inc, SWOT Analysis
Global Blood Therapeutics Inc, Ratios based on current share price
Global Blood Therapeutics Inc, Annual Ratios
Global Blood Therapeutics Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Global Blood Therapeutics Inc (GBT)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら